Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain bleed trial blueprint: will it pave the way for new treatments?

NCT ID NCT06078020

Knowledge-focused Sponsor: University of Edinburgh Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 29, 2026 · Updated 3 times

Summary

This study, called PLINTH, is a feasibility trial for adults who had a stroke from a brain hemorrhage. Researchers want to know if patients and doctors would accept a future platform trial, and how to design it to be inclusive and efficient. About 169 participants will watch an informational video, give consent, and be interviewed at 3 and 14 days after their stroke. No new treatments are being tested here.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study will help design a larger trial that could find better treatments for brain hemorrhage.
What could go wrong
This is a small feasibility study, not testing any treatment. It only gathers opinions and data, so it won't directly improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

169 people

The number who actually took part.

Started

Oct 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with stroke due to intracerebral haemorrhage

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * People aged ≥18 years at the time of diagnosis with symptomatic stroke due to first-ever or recurrent spontaneous (non-traumatic) ICH, most likely to be due to cerebral small vessel disease, confirmed by brain imaging between 1 October 2023 and 30 June 2025 inclusive * One or more management uncertainties exist about the patient's management according to the patient/nearest relative and their responsible clinician * Patient or their nearest relative can be approached for consent to participation in this feasibility study with the aid of simple information delivered by Tailored Talks * Residential postcode in the National Health Service (NHS) Lothian or NHS Lanarkshire regions of Scotland Exclusion Criteria: * People aged \<18 years at the time of ICH diagnosis * Exclusively extra-axial intracranial haemorrhage or ICH definitely attributable to a macrovascular cause (e.g. aneurysm, arteriovenous malformation, cavernoma, cerebral venous sinus thrombosis), tumour, trauma or haemorrhagic transformation of an ischaemic stroke * Responsible clinician deems it inappropriate to approach the patient or their nearest relative (e.g. death appears imminent) * Mental incapacity and no nearest relative, welfare attorney or welfare guardian available at the time of approach * Patient died before approached for consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral hemorrhage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral hemorrhage

Contacts and locations

Locations

  • The Royal Infirmary of Edinburgh

    Edinburgh, City Of Edinburgh, EH16 4SA, United Kingdom

  • University Hospital Monklands

    Airdrie, Lanarkshire, ML6 0JS, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.